The human endocannabnoid system is a homeostatic regulatory system with a substantive role in the dopamenergic. glutamenergic, and sertoerngic neural pathways. It is becoming the subject of modern pharmalogical research, due to its influence over the aforementioned pathways. The endocannabinoid system went long undiscovered due to its unique method of regulaton. The CB1 and CB2 receptors of the endocannabinoid system are located on the presynaptic cleft of the neuronal junction, as opposed to most neural systems, which house their receptors in the post synaptic cleft. This presynaptic positioning allows the endocannabinoid system to register the environment of the synapse. Signifying it as a promising catalyst for treatment and replacement
